![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Medtronic Announces Health Canada Approval for Drug-Coated Balloon
Medtronic Announces Health Canada Approval for Drug-Coated Balloon
![](https://www.fdanews.com/ext/resources/test/Device_Images3/Medtronic.gif?t=1433878552&width=430)
Medtronic Canada has obtained a license from Health Canada license for its IN.PACT Admiral drug-coated balloon.
The product is a primary endovascular device used in patients with peripheral artery disease in the thigh and behind the knee.
The device is used by inserting a compressed balloon into the artery, inflating the balloon to re-open the blockage and then removing it. The device leaves behind medication designed to help prevent the artery from narrowing. — Cynthia Jessup
Upcoming Events
-
21Oct